Ginkgo Bioworks Launches Cost-Effective ADME Profiling Service in US, Offering Competitive Pricing to Beat Chinese or International Vendors.
ByAinvest
Thursday, Jul 17, 2025 9:05 am ET1min read
DNA--
The new service promises to accelerate small molecule drug discovery by providing rapid turnaround times and model-ready datasets enriched with structured metadata for AI-powered insights. Ginkgo's automation and scale enable best-in-class pricing and quality, making it an attractive option for the biopharma industry [1].
Key features of the ADME profiling service include:
- Scalable, automated workflows
- Cost-effective pricing with a price match guarantee against international vendors
- Rapid turnaround to keep pace with modern discovery cycles
- Model-ready datasets, enriched with structured metadata for AI-powered insights
Ginkgo Bioworks' commitment to delivering top-tier, cost-effective services is evident in this latest offering. The company aims to empower researchers by providing early access to rich ADME data, enabling them to prioritize candidates and train predictive models more efficiently [1].
This initiative further solidifies Ginkgo's position in the biopharma industry and underscores its dedication to advancing biological engineering through innovative technologies. The service is a testament to Ginkgo's ability to deliver high-quality products and services at competitive prices, making it a valuable asset for researchers and investors alike.
References:
[1] https://www.prnewswire.com/news-releases/ginkgo-bioworks-launches-adme-profiling-service-using-lab-automation-offering-a-us-based-operation-that-will-match-or-beat-pricing-quotes-from-chinese-or-other-international-vendors-302507668.html
Ginkgo Bioworks has launched a cost-effective ADME profiling service using lab automation, aiming to beat or match international vendors' pricing quotes. The service offers high-throughput ADME profiling, rapid turnaround, and model-ready datasets enriched with structured metadata for AI-powered insights. Ginkgo's automation and scale allow for best-in-class pricing and quality, reinforcing its commitment to providing top-tier services to the biopharma industry.
Ginkgo Bioworks (NYSE: DNA), a leading player in synthetic biology, has introduced a new ADME (Absorption, Distribution, Metabolism, and Excretion) profiling service through its subsidiary, Ginkgo Datapoints. This service leverages the company's proprietary RAC automation technology to offer high-throughput ADME profiling at competitive prices, aiming to match or beat quotes from international vendors, including Chinese competitors [1].The new service promises to accelerate small molecule drug discovery by providing rapid turnaround times and model-ready datasets enriched with structured metadata for AI-powered insights. Ginkgo's automation and scale enable best-in-class pricing and quality, making it an attractive option for the biopharma industry [1].
Key features of the ADME profiling service include:
- Scalable, automated workflows
- Cost-effective pricing with a price match guarantee against international vendors
- Rapid turnaround to keep pace with modern discovery cycles
- Model-ready datasets, enriched with structured metadata for AI-powered insights
Ginkgo Bioworks' commitment to delivering top-tier, cost-effective services is evident in this latest offering. The company aims to empower researchers by providing early access to rich ADME data, enabling them to prioritize candidates and train predictive models more efficiently [1].
This initiative further solidifies Ginkgo's position in the biopharma industry and underscores its dedication to advancing biological engineering through innovative technologies. The service is a testament to Ginkgo's ability to deliver high-quality products and services at competitive prices, making it a valuable asset for researchers and investors alike.
References:
[1] https://www.prnewswire.com/news-releases/ginkgo-bioworks-launches-adme-profiling-service-using-lab-automation-offering-a-us-based-operation-that-will-match-or-beat-pricing-quotes-from-chinese-or-other-international-vendors-302507668.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet